Reimbursement for cardiac telemonitoring in Europe: possible, but only with a joint push
This article was originally published in Clinica
The next steps towards the large-scale adoption of telemonitoring in Europe will be delayed until there is a concerted approach to establishing reimbursement structures. This cannot be enforced at EU level, as reimbursement is a national issue, paid for out of national budgets. But encouraging national authorities to push forward with what, ultimately, will provide the archetypal “win-win” is the responsibility of all key stakeholders.
You may also be interested in...
COVID-19 has forced a rethink in how care should be delivered. Healthcomms Consulting partner Dan Jones says it is an opportunity that must not be squandered.
Certain Cumberlege Review recommendations are making their way into draft UK legislation as the government presses ahead in shaping the UK’s post-Brexit devices regulatory system.
Delivering innovation is still the driving force for medtechs intent on growing in the market, regardless of COVID-19, the disruptive effects of which have intensified with the appearance of new variants, says Jefferies Healthcare equity analyst Raj Denhoy.